Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/38951
Title: Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)
Authors: ZINZANI, P. L.RAMCHANDREN, R.SANTORO, A.PASZKIEWICZ-KOZIK, E.GASIOROWSKI, R.JOHNSON, N. A.OLIVEIRA, J. S. R. deBUCCHERI, V.PERINI, G. F.DICKINSON, M.MCDONALD, A.OZCAN, M.SEKIGUCHI, N.RAUT, M.ZHU, Y.NAHAR, A.MARINELLO, P.KURUVILLA, J.
Citation: ANNALS OF ONCOLOGY, v.31, suppl.4, p.S649-S649, 2020
Appears in Collections:

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.